Drugs / Naphazoline
Naphazoline
also known as
Albalon · Antistin-privine · Gppe nsl soln · Nafazair · Nafazolin · Nafazolina · Naphaz hcl · Naphazoline hcl · +10 more
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | VASOCON | — | 1971-06-07 | fda.gov ↗ |
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05470868 | Feb → May 2023 | ocular hyperemia | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT02601235 | Jan → Aug 2018 | nasal cavity disorder | EMS | Completed | No outcome recorded |
| Phase 3 | NCT00770133 | Feb → Apr 2010 | conjunctivitis | Bausch & Lomb Incorporated | Completed | No outcome recorded |
| Phase 3 | NCT00769886 | Oct → Dec 2008 | conjunctivitis | Bausch & Lomb Incorporated | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01390961 | Aug → Dec 2011 | eye allergy | Hom, Milton M., OD, FAAO | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03324113 Background | Oct 2017 → Nov 2022 | cancer | Sanofi | Completed | No outcome recorded |
Evidence & citations 21 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | naphazoline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01390961 ↗ |
| Known as | Albalon | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Antistin-privine | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Gppe nsl soln | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Nafazair | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Nafazolin | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Nafazolina | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Naphaz hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Naphazoline hcl | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Naphazoline Hydrochloride | “Naphazoline Hydrochloride” NCT02601235 ↗ |
| Known as | Naphazoline hydrochloride component of naphcon-a | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Naphazoline hydrochloride component of opcon-a | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Naphazoline hydrochloride component of vasocon-a | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Naphazoline hydrochloride component of visine | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Naphazoline hydrochloride component of visine-a | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Naphcon forte | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | NSC-35711 | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Opcon | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Known as | Vasocon | ChEMBL registry synonym — accepted as the source's own label CHEMBL761 ↗ |
| Modality | Small molecule | — CHEMBL761 ↗ |
| Route | Other | “Naphazoline ophthalmic solution administered in either the right eye, left eye or both eyes at visit 3 and visit 4.” NCT00770133 ↗ |